Which NS5A targeting agents are available for the treatment of hepatitis C (hep C) infection?

Updated: Oct 07, 2019
  • Author: Vinod K Dhawan, MD, FACP, FRCPC, FIDSA; Chief Editor: BS Anand, MD  more...
  • Print

Several agents are available for NS5A target inhibition in the replication cycle of HCV. These include ledipasvir, ombitasvir, elbasvir, and velpatasvir. These are all approved as part of combination products, as discussed in Direct-Acting Antiviral Agents (DAAs).

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!